ANTIBODIES BINDING TO HUMAN AND CYNOMOLGUS CD3 EPSILON

Anti-CD3epsilon antibodies

FcRn antibodies and methods of use thereof

ROR1 antibody compositions and related methods

MICA BINDING AGENTS

Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory disorders

Method of using anti-APRIL (a proliferation-inducing ligand) antibodies to reduce IGA

Anti-TNF-α-antibodies and functional fragments thereof

Anti-FAM19A5 antibodies and uses thereof

ANTI-ADRENOMEDULLIN (ADM) ANTIBODY OR ANTI-ADM ANTIBODY FRAGMENT OR ANTI-ADM NON-IG SCAFFOLD FOR USE IN INTERVENTION AND THERAPY OF CONGESTION IN A PATIENT IN NEED THEREOF

PARTIAL AGONISTS OF INTERLEUKIN-2

ERIBULIN-BASED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

Antibodies to TIGIT

Anti-TIM-3 antibodies and methods of use thereof

Inhibitors and their uses

High-affinity anti-MERTK antibodies and uses thereof

Bispecific HER2 antibodies and methods of use

ANTIBODIES AND METHODS OF USE THEREOF

ANTIBODIES AND METHODS OF USE THEREOF

Anti-human VSIG4 antibodies and uses thereof

Antibodies that bind to c-type lectin domain family 2 member d (CLEC2D)

ANTIBODIES AND METHODS OF USE THEREOF

Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof

A33 antibody compositions and methods of using the same in radioimmunotherapy

Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications

Polypeptides which bind to interleukin-6 receptor (IL-6R)

Anti-IL13 antibodies and uses thereof

Antibody molecules which bind TNF alpha

CD48 ANTIBODIES AND CONJUGATES THEREOF

Mesothelin binding proteins

METHODS FOR DETECTION OF FOLATE RECEPTOR 1 IN A PATIENT SAMPLE

TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTOR

COMPOSITIONS AND METHODS FOR MAKING AND USING BISPECIFIC ANTIBODIES

COMPOUNDS AND METHODS FOR TUMOUR-SPECIFIC CELL DEPLETION

Antibodies targeting PDL1 and methods of use thereof

Anti-PD-L1 antibodies and their use as therapeutics and diagnostics

Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereof

Method for treating cancer with c-kit antibodies

Antibodies having specificity for BTN2 and uses thereof

Compositions and methods for treatment of diseases involving CXCL1 function

ANTI-SERUM ALBUMIN BINDING VARIANTS

Protein binding to fibronectin B domain

Serum albumin binders

Single-domain VH antibodies directed to norovirus GI.1 and GII.4 and their use

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Anti-TIM-3 antibodies and methods of use thereof

FUSION PROTEINS COMPRISING ENZYME REPLACEMENT THERAPY ENZYMES

BINDING AGENT

Humanized antibodies against CEACAM1

Antibodies that bind CD39 and uses thereof

Neutralizing human anti-CD27 antibodies

Bispecific antigen binding molecule for a costimulatory TNF receptor

Trispecific antagonists

AXL-specific antibodies and uses thereof

Anti-CD303 Monoclonal Antibodies

PD-L1-specific antibodies and methods of using the same

Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)

ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF

Antibody variants

MULTI-SPECIFIC ANTIBODY MOLECULES HAVING SPECIFICITY FOR TNF-ALPHA, IL-17A and IL-17F

Humanized antibodies that recognize alpha-synuclein

Anti-transthyretin antibodies

Antibody-mediated neutralization of chikungunya virus

Radio-labelled antibody fragments for use in the prognosis, diagnosis of cancer as well as for the prediction of cancer therapy response

Anti-ErbB3 antibodies and uses thereof

Nucleic acid molecules encoding chimeric antigen receptors targeting B-cell maturation antigen and uses thereof

Methods of using chimeric antigen receptors targeting B-cell maturation antigen and uses thereof

Methods, compositions, and kits for detection of aspergillosis

Bispecific antibodies against HER2 and CD3

Anti-coagulation factor XI antibodies

Afucosylated monoclonal antibody

Vectors comprising nucleic acids encoding anti-OX40 antibodies

ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY POLYPEPTIDES

Combination treatment for cancer with anti-BCMA binding protein and proteosome inhibitor

Coiled coil immunoglobulin fusion proteins and compositions thereof

Method of treating or delaying progression of an epidermal growth factor receptor (EGFR)-related disorder by administering activatable EGFR-binding antibodies

Anti-TIGIT antibodies

Bispecific antibodies with specific binding to CD47 and PD-L1

Humanized monoclonal antibodies that target VE-PTP (HPTP-beta)

EXPRESSION CONSTRUCTS, HOST CELLS, AND METHODS FOR PRODUCING INSULIN

ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS

Plectin-1 binding antibodies and uses thereof

Cancer treatments

Anti-isoAsp7 amyloid β (Aβ) antibodies and uses thereof

ANTI-DENGUE VIRUS ANTIBODIES AND USES THEREOF

Heterodimeric antibody Fc-containing proteins and methods for production thereof

CRTAM antibodies and methods of treating cancer

CTLA-4 antibodies and uses thereof

Disrupting FC receptor engagement on macrophages enhances efficacy of anti-SIRPalpha antibody therapy

Claudin 6 antibodies and uses thereof

Methods of treating pruritic disease with IL-31 monoclonal antibodies

Anti-IL-25 antibodies and uses thereof

IL-5 antibody, antigen binding fragment thereof, and medical application therefor

DUAL PDGF/VEGF ANTAGONISTS

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

Anti-N3pGlu amyloid beta peptide antibodies and uses thereof

Methods of treating C5-associated diseases comprising administering anti-C5 antibodies

Polynucleotides encoding anti-C5 antibodies

Anti-human MUC1 antibody Fab fragment

GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) ANTIBODIES AND METHODS OF USE THEREOF

Anti-coagulation factor XI antibodies

Compositions and methods for treatment of cancer

Anti-HER2 Antibodies and Immunoconjugates

Methods and compositions related to antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72)

Anti-CD276 polypeptides, proteins, and chimeric antigen receptors

Stable antibody variable domain framework combinations and methods of use thereof

Anti-TREM1 antibodies and related methods

B7-H4 antibodies and methods of use thereof

Antibody chemically induced dimerizer (AbCID) as molecular switches for regulating cellular therapies

TIGIT antibody, antigen-binding fragment thereof, and medical use thereof

Dual specific antibodies for binding interleukin 4 (IL4) and interleukin 5 (IL5)

Antibody variants

Nano-theranostics for Parkinson's disease

Method of treating an allergy with allergen-specific monoclonal antibodies

Antibody to Epstein Barr Virus and Uses Thereof

Dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS)

Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer

NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A

Multispecific antibodies against CD40 and CD137

Human antibodies to the human glucagon receptor and methods of use thereof to lower blood glucose or ketone levels

Anti-IL2 receptor gamma antigen-binding proteins

Anti-IL1RAP antibodies

Methods of treating systemic lupus erythematosus using a domain antibody directed against CD28

ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE

CD47 antigen binding unit and uses thereof

Fibronectin based scaffold proteins

RECOMBINANT FOLLISTATIN-FC FUSION PROTEINS AND USE IN TREATING DUCHENNE MUSCULAR DYSTROPHY

Antibody-drug conjugates and uses thereof

Human anti-VEGFR-2/KDR antibodies

Systems and methods for miniaturized antenna for wireless power transmissions

Humanized antibodies with ultralong complementary determining regions

Fn14 Binding Proteins and Uses Thereof

Methods for treating type 1 diabetes using glucagon receptor antagonistic antibodies

Anti-CD123 antibodies and conjugates and derivatives thereof

ANTIBODIES AGAINST PD-L1

BTLA agonist antibodies and uses thereof

Bispecific anti-CD28 × anti-CD22 antibodies and uses thereof

Single domain antibodies to programmed cell death protein 1 (PD-1)

Single domain antibodies to programmed cell death (PD-1)

Method of reducing mesothelin-expressing tumor burden by administration of T cells comprising mesothelin-targeted chimeric antigen receptors

Humanized monoclonal antibodies that target VE-PTP (HPTP-β)

Anti-complement factor C1Q antibodies and uses thereof

Methods of inducing complement activity

Polynucleotides encoding anti-ApoC3 antibodies

Broadly neutralizing antibodies against HIV

Anti-respiratory syncytial virus antibodies, methods of their generation and use

Constructs having a SIRP-α domain or variant thereof

Polypeptides which bind C-X-C chemokine receptor type 4 (CXCR4) and methods of treating or reducing the risk of fibrosis and cancer

Anti-age antibodies for treating inflammation and auto-immune disorders

Anti-CD38 binding domains

Bispecific antigen binding molecule for a costimulatory TNF receptor

ANTIBODY MOLECULES

ANTI IL-36R ANTIBODIES

Anti-c-Met antibody and use thereof

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof

PD-1-binding molecules and methods of use thereof

Bispecific T cell activating antigen binding molecules

Single chain variable fragment CD3 binding proteins

Antibodies to human erythroferrone and uses thereof

Antagonists targeting the TGF-β pathway

Antibodies to alpha-synuclein and uses thereof

Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)

CD38-binding proteins comprising de-immunized Shiga toxin A subunit effectors

Multispecific antigen-binding molecules having blood coagulation factor VIII (FVIII) cofactor function-substituting activity and pharmaceutical formulations containing such a molecule as an active ingredient

Multispecific antibody analogs comprising a common light chain, and methods of their preparation and use

Antibody Fc variants for increased blood half-life

Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods

Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

Anti-epidermal growth factor receptor (EGFR) antibodies

Isolated nucleic acids encoding anti-sortilin antibodies

Anti-CD166 antibodies and uses thereof

Method of detecting TIM-3 using antibody molecules to TIM-3

Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the same

Claudin 5 antibody, and medicine containing said antibody

HUMANIZED ANTI-TAU(PS422) ANTIBODIES AND METHODS OF USE

Fungal Detection Using Mannan Epitope

Anti-respiratory syncytial virus antibodies, and methods of their generation and use

Canine antibody libraries

DISCOVERING AND PRODUCING CONDITIONALLY ACTIVE BIOLOGIC PROTEINS IN THE SAME EUKARYOTIC CELL PRODUCTION HOSTS

Anti-MCAM Antibodies And Associated Methods Of Use

Heterodimeric antibodies that bind CD3 and PSMA

Polynucleotides encoding humanized antibodies against CEACAM1

BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

Human antigen binding proteins that bind β-klotho, FGF receptors and complexes thereof

PROTEINS BINDING NKG2D, CD16, AND EGFR, HLA-E, CCR4, OR PD-L1

Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof

Anti-PD1 antibodies and their use as therapeutics and diagnostics

Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains

Antibodies for IL-17C

Anti-IL-22R antibodies

Antibody variants

Anti-ApoC3 antibodies

Antibodies and Vaccines for Use in Therapeutic and Diagnostic Methods for Alpha-Synuclein-Related Disorders

CELLS, VERTEBRATES, POPULATIONS & METHODS

Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery

Anti-VWF D'D3 single-domain antibodies fuse to clotting factors

HER3 binding agents and uses thereof

Anti-TLR4 antibodies and uses thereof

Antibodies capable of binding HLA-A2/TyrD in an HLA restricted manner and uses thereof

HUMANIZED AFFINITY MATURED ANTI-FcRn ANTIBODIES

Multi-chain polypeptide-containing tri-specific binding molecules

Engineered T cell receptors and immune therapy using the same

IL-11Rα antibodies

ANG2-BINDING MOLECULES

Anti-C5A antibodies

Full spectrum anti-dengue antibody

Methods of treating ulcerative colitis

Antibody-mediated neutralization of ebolaviruses

Heterodimeric antibodies that bind CD3 and CD38

FIXaxFX bispecific antibody with common light chain

Bispecific HER2 and CD3 binding molecules

Anti-CD276 antibodies (B7H3)

Methods of treating immune diseases by administering antibody polypeptides that antagonize CD40

PDL1-binding proteins

Anti-human CD69 antibody, and use thereof for medical purposes

Tumor-targeted agonistic CD28 antigen binding molecules

Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof

BAFF-R BISPECIFIC T-CELL ENGAGER ANTIBODY

Humanized or chimeric CD3 antibodies

Anti-CD96 antibodies and methods of use thereof

Anti-human natural killer cell inhibitory receptor group 2A protein (NKG2A) antibodies

Tri-specific binding molecules that specifically bind to multiple cancer antigens

Biparatopic polypeptides antagonizing Wnt signaling in tumor cells

IL-11 antibodies

COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST

Antibody that binds to VEGF and IL-1beta and methods of use

Anti-ANGPTL ⅜ complex antibodies and methods of using the same

ANGPTL3/8 complexes and methods of using the same

Anti-amyloid-beta antibodies

Broadly Neutralizing Monoclonal Antibodies Against HIV-1 V1V2 Env Region

Methods of treating filovirus infections utilizing bispecific antibodies and fusion proteins that bind EBOV and NPC1

Antigen binding proteins

Inhibitors and their uses

PSEUDOMONAS AERUGINOSA PCRV BINDING SINGLE VARIABLE DOMAIN ANTIBODIES

Tissue factor pathway inhibitor antibodies and uses thereof

CD38 modulating antibody

Polypeptides

Immunotherapy using antibodies that bind programmed death ligand-1 (PD-L1)

PD-1/TIM-3 BI-SPECIFIC ANTIBODIES, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME

Anti-CD3-binding domains and antibodies comprising them, and methods for their generation and use

Agent, uses and methods for treatment

Anti-PD-1 antibodies

Antibodies against TIM3 and uses thereof

IP-10 antibodies and their uses

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Anti-tenascin C antibodies and uses thereof

FGL2 antibodies and binding fragments thereof and uses thereof

Binding moieties for biofilm remediation

Neutralizing anti-influenza B antibodies and uses thereof

Polyomavirus neutralizing antibodies

Cell engaging binding molecules

ANTI-OX40 ANTIBODIES AND THEIR USES

MODIFIED PSEUDOMONAS EXOTOXIN A

Syndecan-1 (CD138) binding agents and uses thereof

Anti-GARP protein

Bispecific antagonist comprising a LAG-3 binding domain

Multispecific binding constructs against checkpoint molecules and uses thereof

Hetero-dimeric multi-specific antibody format targeting at least CD3 and HSA

HUMANIZED AFFINITY MATURED ANTI-FcRn ANTIBODIES

Anti-CEACAM6 antibodies and uses thereof

Anti-CD47 antibodies and uses thereof

MODIFIED ANTIBODY CONSTANT REGION

Human IL-23 Antigen Binding Proteins

Humanized antibodies binding to amyloid-beta (A-beta)

SPD-1 variant# FC fusion proteins

Humanized anti-PACAP antibodies

Humanized anti-PACAP antibodies

Car T-cells recognizing cancer-specific IL 13Ra2

Nanoparticle platform for antibody and vaccine delivery

Host cells for use in an inducible coexpression system

COMMON LIGHT CHAINS AND METHODS OF USE

Antibodies and chimeric antigen receptors specific for CD19

Anti-human 4-1BB antibodies and uses thereof

Bispecific binding proteins and uses thereof

Anti-CD8 antibodies and uses thereof

Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor

Human PAC1 antibodies

Anti-PACAP antibodies

Humanized anti-ACTH antibodies and use thereof

Methods of neutralizing IL-8 biological activity

STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF

FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE

Methods of reducing toxicity induced by Amyloid beta (A-beta) oligomers using antibodies specific to A-beta oligomers

BROADLY NEUTRALIZING ANTIBODIES AGAINST HIV

Alzheimer Aβ peptide binding polypeptide

Method of treating cancer using a combination of entinostat and an anti-CSF-1R antibody

COMPOSITIONS AND METHODS RELATING TO UNIVERSAL GLYCOFORMS FOR ENHANCED ANTIBODY EFFICACY

Antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) and related methods

VARIANTS OF CD38 ANTIBODY AND USES THEREOF

HUMANIZED ANTI-N-CADHERIN ANTIBODIES AND USES THEREOF

CD123 binding proteins and related compositions and methods

HLA-DR CAR-T COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

Antibody inhibitors of IL-38 and methods of use thereof for treating or reducing the likelihood of cancer in a subject

Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopenia

High-affinity anti-VEGF antibody

Methods of detecting pyroglutamate amyloid beta protein (3pE Aβ) using anti-3pE Aβ antibodies

Epitopes in the RNA recognition motif 1 (RRM1) of TDP-43 and misfolding-selective antibodies thereto

Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120

Humanized anti-PACAP antibodies

Development of masked therapeutic antibodies to limit off-target effects